Loading...
ROCO
6543
Market cap25mUSD
Jul 09, Last price  
18.00TWD
1D
-0.55%
1Q
-17.62%
IPO
-7.26%
Name

Perfect Medical Industry Co Ltd

Chart & Performance

D1W1MN
ROCO:6543 chart
P/E
15.15
P/S
1.06
EPS
1.19
Div Yield, %
4.83%
Shrs. gr., 5y
5.91%
Rev. gr., 5y
-0.72%
Revenues
779m
+4.68%
675,711,000807,759,000724,608,000677,036,000734,133,000744,157,000779,015,000
Net income
54m
-39.13%
36,443,000100,694,00038,772,00014,270,00040,089,00089,123,00054,247,000
CFO
108m
-24.94%
95,970,000118,194,0004,443,000105,613,000149,873,000143,542,000107,745,000
Dividend
Apr 23, 20250.87 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Perfect Medical Industry Co., Ltd. is a Taiwanese enterprise specializing in the manufacturing and global distribution of a diverse range of health and medical supplies. Their extensive product portfolio encompasses critical medical consumables, including specialized tubing and needle sets for procedures like hemodialysis and A.V. fistula, as well as various huber and winged needle sets, blood transfusion and safety infusion sets, safety extension sets, I.V. locks, disposable syringes, and medical face masks. These offerings are marketed under the 'PF' brand, reaching a broad international customer base across Asia, Africa, Europe, and South America. Established in 1989, the company maintains its headquarters in Changhua, Taiwan.
IPO date
Mar 27, 2019
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT